Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Amgen Inc

AMGN Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

$AMGN stock is featured in our Rob Bresnahan, Sheldon Whitehouse, and Shelley Moore Capito strategies.

All Strategies
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of AMGN by members of U.S. Congress

Politician Type Traded
David Taylor House / R Sale $1,001 - $15,000 Aug 26, 2026
David Taylor House / R Sale $1,001 - $15,000 Aug 26, 2026
Sheldon Whitehouse Senate / D Sale (Partial) $1,001 - $15,000 Aug 12, 2026
Ro Khanna House / D Sale $1,001 - $15,000 Jul 20, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 Jul 08, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 Jun 30, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 Jun 16, 2026
David Taylor House / R Purchase $1,001 - $15,000 Jun 05, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 Jun 02, 2026
Ro Khanna House / D Purchase $15,001 - $50,000 May 27, 2026
Ro Khanna House / D Sale $15,001 - $50,000 May 15, 2026
Ro Khanna House / D Purchase $15,001 - $50,000 May 01, 2026
Ro Khanna House / D Sale $15,001 - $50,000 Apr 24, 2026
Maria Elvira Salazar House / R Sale $15,001 - $50,000 Apr 17, 2026
Ro Khanna House / D Sale $15,001 - $50,000 Mar 30, 2026
Alan Armstrong Senate / R Sale (Full) $15,001 - $50,000 Mar 27, 2026
Maria Elvira Salazar House / R Purchase $15,001 - $50,000 Mar 24, 2026
David Taylor House / R Sale $1,001 - $15,000 Feb 26, 2026
Ro Khanna House / D Purchase $15,001 - $50,000 Feb 24, 2026
David Taylor House / R Sale $1,001 - $15,000 Jan 29, 2026
Ro Khanna House / D Sale $15,001 - $50,000 Jan 23, 2026
David Taylor House / R Purchase $1,001 - $15,000 Jan 16, 2026
David Taylor House / R Sale $1,001 - $15,000 Dec 03, 2025
David Taylor House / R Sale $1,001 - $15,000 Dec 03, 2025
Marjorie Taylor Greene House / R Purchase $1,001 - $15,000 Oct 24, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Sep 29, 2025
Lisa C. McClain House / R Sale $1,001 - $15,000 Sep 25, 2025
Marjorie Taylor Greene House / R Purchase $1,001 - $15,000 Sep 11, 2025
Sheldon Whitehouse Senate / D Sale (Full) $1,001 - $15,000 Sep 04, 2025
Lisa C. McClain House / R Purchase $1,001 - $15,000 Jun 24, 2025
Cliff Bentz House / R Purchase $1,001 - $15,000 Jun 06, 2025
Marjorie Taylor Greene House / R Purchase $1,001 - $15,000 May 14, 2025
Jefferson Shreve House / R Sale $15,001 - $50,000 May 12, 2025
Marjorie Taylor Greene House / R Purchase $1,001 - $15,000 May 05, 2025
Jared Moskowitz House / D Purchase $1,001 - $15,000 Apr 16, 2025
Jared Moskowitz House / D Purchase $1,001 - $15,000 Apr 16, 2025
Tommy Tuberville Senate / R Sale (Full) $15,001 - $50,000 Apr 15, 2025
Jefferson Shreve House / R Purchase $15,001 - $50,000 Apr 11, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Apr 09, 2025
Robert Bresnahan House / R Sale $1,001 - $15,000 Apr 08, 2025
Jefferson Shreve House / R Purchase $15,001 - $50,000 Feb 24, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Feb 19, 2025
Daniel Meuser House / R Sale $1,001 - $15,000 Feb 11, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Ro Khanna House / D Purchase $1,001 - $15,000 Jan 22, 2025
Emily Randall House / D Sale $1,001 - $15,000 Jan 06, 2025
Virginia Foxx House / R Purchase $1,001 - $15,000 Dec 06, 2024
Julia Letlow House / R Sale $1,001 - $15,000 Nov 19, 2024
Ro Khanna House / D Sale $15,001 - $50,000 Nov 15, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Nov 12, 2024
AMGN Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
AMGN Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
AMGN Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in AMGN holdings by institutional investors

Quarterly net insider trading by AMGN's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $80,000 Jul 20, 2026 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $2,440,000 Jul 20, 2026 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark Tariff (miscellaneous tariff bills)
  • $50,000 Jul 20, 2026 Issue: Medicare/Medicaid
  • $60,000 Jul 20, 2026 Issue: Budget/Appropriations Labor Issues/Antitrust/Workplace Copyright/Patent/Trademark Health Issues Medicare/Medicaid Taxation/Internal Revenue Code
  • $7,500 Jul 20, 2026 Issue: Health Issues
  • $50,000 Jul 20, 2026 Issue: Health Issues
  • $60,000 Jul 20, 2026 Issue: Immigration Health Issues Medicare/Medicaid
  • $60,000 Jul 19, 2026 Issue: Medicare/Medicaid Health Issues
  • $10,000 Jul 19, 2026 Issue: Health Issues
  • $50,000 Jul 19, 2026 Issue: Pharmacy
  • $60,000 Jul 17, 2026 Issue: Health Issues Budget/Appropriations
  • $60,000 Jul 16, 2026 Issue: Health Issues Medicare/Medicaid Budget/Appropriations
  • $50,000 Jul 16, 2026 Issue: Medicare/Medicaid
  • $50,000 Jul 16, 2026 Issue: Health Issues
  • $37,500 Jul 10, 2026 Issue: Health Issues
  • $5,000 Jun 12, 2026 Issue: Health Issues
  • $10,000 Apr 22, 2026 Issue: Health Issues
  • $2,580,000 Apr 20, 2026 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark Tariff (miscellaneous tariff bills)
  • $80,000 Apr 20, 2026 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $60,000 Apr 20, 2026 Issue: Health Issues Medicare/Medicaid Budget/Appropriations
  • $50,000 Apr 20, 2026 Issue: Health Issues
  • $60,000 Apr 20, 2026 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Budget/Appropriations Labor Issues/Antitrust/Workplace Copyright/Patent/Trademark
  • $60,000 Apr 20, 2026 Issue: Health Issues Medicare/Medicaid Immigration
  • $50,000 Apr 18, 2026 Issue: Medicare/Medicaid
  • $50,000 Apr 18, 2026 Issue: Health Issues
  • $60,000 Apr 17, 2026 Issue: Medicare/Medicaid Health Issues
  • $7,500 Apr 17, 2026 Issue: Health Issues
  • $60,000 Apr 17, 2026 Issue: Health Issues Budget/Appropriations
  • $37,500 Apr 13, 2026 Issue: Health Issues
  • $50,000 Apr 09, 2026 Issue: Pharmacy
  • $80,000 Jan 20, 2026 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $60,000 Jan 20, 2026 Issue: Medicare/Medicaid Budget/Appropriations Health Issues
  • $60,000 Jan 20, 2026 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Budget/Appropriations Labor Issues/Antitrust/Workplace Copyright/Patent/Trademark
  • $3,550,000 Jan 20, 2026 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark Tariff (miscellaneous tariff bills)
  • $50,000 Jan 20, 2026 Issue: None
  • $60,000 Jan 20, 2026 Issue: Medicare/Medicaid Health Issues
  • $50,000 Jan 20, 2026 Issue: Health Issues
  • $60,000 Jan 20, 2026 Issue: Health Issues Medicare/Medicaid Immigration
  • $20,000 Jan 19, 2026 Issue: Health Issues
  • $50,000 Jan 19, 2026 Issue: Health Issues
  • $50,000 Jan 19, 2026 Issue: Pharmacy
  • $50,000 Jan 18, 2026 Issue: Medicare/Medicaid
  • $60,000 Jan 16, 2026 Issue: Health Issues Budget/Appropriations
  • $7,500 Jan 16, 2026 Issue: Health Issues
  • $37,500 Jan 12, 2026 Issue: Health Issues
  • $50,000 Oct 20, 2025 Issue: Pharmacy
  • $2,580,000 Oct 20, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark Tariff (miscellaneous tariff bills)
  • $3,550,000 Oct 20, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark Tariff (miscellaneous tariff bills)
  • $7,500 Oct 20, 2025 Issue: Health Issues
  • $60,000 Oct 20, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Budget/Appropriations Labor Issues/Antitrust/Workplace Copyright/Patent/Trademark
  • $60,000 Oct 20, 2025 Issue: Health Issues Medicare/Medicaid Immigration
  • $50,000 Oct 20, 2025 Issue: Health Issues
  • $60,000 Oct 20, 2025 Issue: Health Issues Budget/Appropriations
  • $50,000 Oct 19, 2025 Issue: None
  • $60,000 Oct 19, 2025 Issue: Medicare/Medicaid Health Issues
  • $50,000 Oct 19, 2025 Issue: Health Issues
  • $50,000 Oct 17, 2025 Issue: Medicare/Medicaid
  • $60,000 Oct 15, 2025 Issue: Health Issues Medicare/Medicaid Budget/Appropriations
  • $15,000 Oct 14, 2025 Issue: Health Issues
  • $37,500 Oct 14, 2025 Issue: Health Issues
  • $80,000 Oct 11, 2025 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $7,500 Sep 25, 2025 Issue: Health Issues
  • $50,000 Jul 21, 2025 Issue: Medicare/Medicaid
  • $50,000 Jul 21, 2025 Issue: Medicare/Medicaid
  • $15,000 Jul 21, 2025 Issue: Health Issues
  • $60,000 Jul 21, 2025 Issue: Medicare/Medicaid Immigration Health Issues
  • $50,000 Jul 21, 2025 Issue: Health Issues
  • $60,000 Jul 19, 2025 Issue: Medicare/Medicaid
  • $50,000 Jul 19, 2025 Issue: None
  • $80,000 Jul 19, 2025 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $50,000 Jul 18, 2025 Issue: Health Issues
  • $60,000 Jul 18, 2025 Issue: Copyright/Patent/Trademark Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Budget/Appropriations Labor Issues/Antitrust/Workplace
  • $60,000 Jul 18, 2025 Issue: Health Issues Budget/Appropriations
  • $35,000 Jul 17, 2025 Issue: Health Issues
  • $60,000 Jul 16, 2025 Issue: Health Issues Medicare/Medicaid Budget/Appropriations
  • $7,500 Jul 14, 2025 Issue: Health Issues
  • $60,000 Apr 21, 2025 Issue: Health Issues Medicare/Medicaid Immigration
  • $3,610,000 Apr 21, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark Tariff (miscellaneous tariff bills)
  • $60,000 Apr 21, 2025 Issue: Health Issues Budget/Appropriations
  • $60,000 Apr 21, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Budget/Appropriations Labor Issues/Antitrust/Workplace Copyright/Patent/Trademark
  • $50,000 Apr 21, 2025 Issue: Health Issues
  • $80,000 Apr 21, 2025 Issue: Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
  • $10,000 Apr 20, 2025 Issue: Health Issues
  • $60,000 Apr 18, 2025 Issue: Medicare/Medicaid
  • $50,000 Apr 18, 2025 Issue: Health Issues
  • $50,000 Apr 18, 2025 Issue: Medicare/Medicaid
  • $50,000 Apr 17, 2025 Issue: Medicare/Medicaid
  • $7,500 Apr 15, 2025 Issue: Health Issues
  • $60,000 Apr 15, 2025 Issue: Health Issues Medicare/Medicaid Budget/Appropriations
  • $30,000 Apr 11, 2025 Issue: Health Issues
  • $2,980,000 Feb 04, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $60,000 Jan 22, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Budget/Appropriations Labor Issues/Antitrust/Workplace Copyright/Patent/Trademark
  • $2,780,000 Jan 21, 2025 Issue: Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark
  • $60,000 Jan 21, 2025 Issue: Health Issues Medicare/Medicaid Immigration
  • $60,000 Jan 21, 2025 Issue: Medicare/Medicaid Pharmacy
  • $50,000 Jan 20, 2025 Issue: Health Issues
  • $60,000 Jan 20, 2025 Issue: Health Issues
  • $20,000 Jan 20, 2025 Issue: Health Issues
  • $50,000 Jan 20, 2025 Issue: Medicare/Medicaid
  • $60,000 Jan 19, 2025 Issue: Medicare/Medicaid

Former government officials who have lobbied for AMGN

157 former government officials from 91 congressional offices at 36 lobbying firms have lobbied for AMGN, most recently Jul 20, 2026.

  • John B. Shadegg
    Paul Edattel House Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg Formerly with John B. Shadegg · TODD STRATEGY GROUP · Jul 20, 2026
  • Daniel Todd Senate Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Amin Ctr. Medicare & Medicaid Formerly Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Am · TODD STRATEGY GROUP · Jul 20, 2026
  • Brett Guthrie
    Eric Bergren House Chief of Staff, Rep. Brett Guthrie; Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Chief of Staff - Rep. Ron Lewis; Intern, Rep. Bill Baker Formerly with Brett Guthrie · TODD STRATEGY GROUP · Jul 20, 2026
  • Brett Guthrie
    Katherine Cotton House Staff Assistant, Legislative Correspondent, Legislative Assistant - U.S. Representative Brett Guthrie Formerly with Brett Guthrie · TODD STRATEGY GROUP · Jul 20, 2026
  • Lee Terry
    Nicolas Magallanes House Senior Advisor - House Republican Conference; Policy Advisor/Professional Staff Member - U.S. Representative Lee Terry/Energy and Commerce Committee; Legislative Correspondent/Legislative Aide - U.S. Senator Lamar Alexander Formerly with Lee Terry · TODD STRATEGY GROUP · Jul 20, 2026
  • Darrell Issa
    Molly Fromm House New (continued) U.S. House Cmte on Oversight and Government Reform, Deputy General Counsel, Parliamentarian, Professional Staff Member; U.S. Rep. Darrell Issa, Leg. Asst., Leg. Corr., Staff Asst., Intern Formerly with Darrell Issa · THE NICKLES GROUP, LLC · Jul 20, 2026
  • Michael A. Arcuri
    Christopher Wilcox House LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings Formerly with Michael A. Arcuri · WILLIAMS AND JENSEN, PLLC · Jul 20, 2026
  • Chuck Grassley
    Jeanne Haggerty Senate Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member Formerly with Chuck Grassley · WILLIAMS AND JENSEN, PLLC · Jul 20, 2026
See all 157 on the Revolving Door dashboard

AMGN Estimated quarterly lobbying spending

AMGN Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
AMGN Income Statement
AMGN Balance Sheet
AMGN Cash Flow
U.S. Patents

New AMGN patent grants

  • Patent Title: Handheld drug delivery device Apr. 28, 2026
  • Patent Title: Handheld drug delivery device Apr. 21, 2026
  • Patent Title: Handheld drug delivery device Dec. 16, 2025
  • Patent Title: Vial sleeve Nov. 04, 2025
  • Patent Title: Handheld drug delivery device Oct. 07, 2025
  • Patent Title: Handheld drug delivery device Oct. 07, 2025
  • Patent Title: Handheld drug delivery device Sep. 30, 2025
  • Patent Title: Handheld drug delivery device Jul. 15, 2025
  • Patent Title: Handheld drug delivery device Jul. 08, 2025
  • Patent Title: Handheld drug delivery device Jun. 10, 2025
  • Patent Title: Handheld drug delivery device Jun. 10, 2025
  • Patent Title: Handheld drug delivery device Jun. 10, 2025
  • Patent Title: Handheld drug delivery device Jun. 10, 2025
  • Patent Title: Handheld drug delivery device Jun. 10, 2025
  • Patent Title: Pharmaceutical product cassette for an injection device May. 20, 2025
  • Patent Title: Handheld drug delivery device Apr. 29, 2025
  • Patent Title: Handheld drug delivery device Apr. 22, 2025
  • Patent Title: Handheld drug delivery device Apr. 15, 2025
  • Patent Title: Handheld drug delivery device Apr. 15, 2025
  • Patent Title: Handheld drug delivery device Apr. 15, 2025
  • Patent Title: On-body injector Apr. 08, 2025
  • Patent Title: Autoinjector with removable cap Mar. 04, 2025
  • Patent Title: Medical packaging tray May. 12, 2020
  • Patent Title: Handheld drug delivery device May. 05, 2020
  • Patent Title: Autoinjector with removable cap Mar. 17, 2020
  • Patent Title: On-body injector Mar. 17, 2020
  • Patent Title: On-body injector for drug delivery Mar. 17, 2020
  • Patent Title: On-body injector for drug delivery Mar. 10, 2020
  • Patent Title: On-body injector for drug delivery Mar. 10, 2020
  • Patent Title: Autoinjector Oct. 22, 2019
  • Patent Title: Handheld drug delivery device Jul. 16, 2019
  • Patent Title: Autoinjector with removable cap Jun. 18, 2019
  • Patent Title: On-body injector for drug delivery Feb. 05, 2019
  • Patent Title: On-body injector Jan. 15, 2019
  • Patent Title: Autoinjector Oct. 09, 2018
  • Patent Title: Injection device Oct. 02, 2018
  • Patent Title: Vial sleeve Aug. 28, 2018
  • Patent Title: Handheld drug delivery device Aug. 28, 2018
  • Patent Title: On-body injector for drug delivery Aug. 21, 2018
  • Patent Title: Autoinjector with removable autoinjector cap Jul. 03, 2018
  • Patent Title: On-body injector for drug delivery Jul. 03, 2018
  • Patent Title: On-body injector for drug delivery Jun. 26, 2018
  • Patent Title: Pharmaceutical product cassette for an injection device May. 29, 2018
  • Patent Title: Autoinjector with removable cap May. 29, 2018
  • Patent Title: Autoinjector with removable cap May. 29, 2018
  • Patent Title: Display screen with graphical user interface for activating drug delivery and communicating drug delivery information Apr. 24, 2018
  • Patent Title: Autoinjector with removable cap Mar. 27, 2018
  • Patent Title: On-body injector Mar. 20, 2018
  • Patent Title: Injection device Jan. 16, 2018
  • Patent Title: Autoinjector Sep. 05, 2017
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to AMGN from public contracts

AMGN News

Recent insights relating to AMGN

CNBC Recommendations

Recent picks made for AMGN stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in AMGN

AMGN Analyst Ratings

AMGN Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
AMGN Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $AMGN stock a Buy, Sell, or Hold?

  • What is the price target for $AMGN stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

AMGN Top Shareholders
Shareholder
Shares Held
AMGN Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $AMGN stock?

  • Who owns the most shares of $AMGN stock?

  • What funds own $AMGN stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

AMGN Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view AMGN Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About AMGN

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis, which has been further strengthened with the launch of new drugs in blood cancers (Blincyto) and solid tumors (Imdelltra). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.

  • Address Thousand Oaks, CA
  • Market Cap 219.5 billion
  • Employees 31,500
  • Industrial Classification Biological Products, (No Diagnostic Substances)

Amgen Inc (AMGN) Historical Stock Prices

Amgen Inc (AMGN) closed at $406.04 on September 24, 2026. Over the past year its adjusted close ranged from $263.89 to $444.12. Daily prices go back to January 2, 2014, 3,201 trading days in all.

  • 1 month-8.19%
  • 3 months+15.74%
  • Year to date+26.59%
  • 1 year+49.44%
  • 3 years+66.47%
  • 5 years+122.11%
  • Max+400.63%
See every congressional and insider trade on the AMGN price chart

Quiver Premium charts AMGN's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 24, 2026 406.09 409.99 403.88 406.04 406.04 2,525,238
Sep 23, 2026 410.09 415.76 404.34 406.09 406.09 2,822,969
Sep 22, 2026 405.25 413.00 398.52 410.24 410.24 3,720,961
Sep 21, 2026 385.71 394.50 381.90 393.16 393.16 2,889,256
Sep 18, 2026 378.51 386.50 378.51 385.65 385.65 8,528,354
Sep 17, 2026 379.15 382.49 376.08 379.78 379.78 3,234,953
Sep 16, 2026 377.01 379.11 374.46 376.35 376.35 2,401,881
Sep 15, 2026 380.23 381.04 375.15 375.65 375.65 2,609,303
Sep 14, 2026 381.94 384.61 376.76 381.50 381.50 2,714,874
Sep 11, 2026 386.13 386.99 377.22 377.35 377.35 2,272,874
Sep 10, 2026 387.84 391.67 381.51 382.47 382.47 3,431,980
Sep 9, 2026 393.06 395.55 389.28 391.27 391.27 2,922,839
Sep 8, 2026 408.90 410.02 391.17 393.17 393.17 6,831,664
Sep 4, 2026 437.03 441.85 435.00 437.23 437.23 1,656,089
Sep 3, 2026 445.67 445.81 438.08 444.12 444.12 1,842,496
Sep 2, 2026 440.65 445.57 435.00 442.84 442.84 2,286,291
Sep 1, 2026 435.30 438.65 431.00 438.12 438.12 2,359,102
Aug 31, 2026 428.59 431.85 426.00 429.88 429.88 2,343,377
Aug 28, 2026 437.89 437.89 430.72 432.42 432.42 1,739,954
Aug 27, 2026 433.08 442.13 431.01 436.99 436.99 1,762,555
Aug 26, 2026 441.00 442.88 438.24 440.34 440.34 2,289,655
Aug 25, 2026 443.26 447.03 441.26 442.24 442.24 2,101,323
Aug 24, 2026 440.31 445.87 435.51 443.84 443.84 2,464,347
Aug 21, 2026$2.52 dividend 431.72 440.51 429.38 439.33 439.33 2,114,751
Aug 20, 2026 435.78 441.34 431.07 433.73 431.26 2,914,326
Aug 19, 2026 430.24 443.20 429.38 442.36 439.84 2,543,982
Aug 18, 2026 421.64 427.39 420.72 425.28 422.86 2,591,635
Aug 17, 2026 412.98 419.60 410.40 419.38 416.99 2,880,643
Aug 14, 2026 413.76 416.03 410.50 415.21 412.84 2,036,768
Aug 13, 2026 419.92 420.26 415.78 417.84 415.46 2,778,004
Aug 12, 2026 413.31 418.19 409.00 416.18 413.81 2,065,699
Aug 11, 2026 415.52 421.79 412.20 414.30 411.94 2,029,780
Aug 10, 2026 408.46 417.36 406.42 417.20 414.82 1,959,757
Aug 7, 2026 404.09 411.60 401.07 410.94 408.60 1,821,551
Aug 6, 2026 413.71 418.40 401.20 404.85 402.54 2,609,054
Aug 5, 2026 393.36 416.24 391.00 407.83 405.50 5,750,739
Aug 4, 2026 380.75 390.92 376.02 390.02 387.80 3,622,724
Aug 3, 2026 388.50 391.03 375.96 378.87 376.71 3,443,058
Jul 31, 2026 382.00 386.82 379.34 385.16 382.96 1,954,553
Jul 30, 2026 379.75 388.41 378.21 387.64 385.43 3,005,306
Jul 29, 2026 395.03 397.88 386.58 387.64 385.43 3,005,382
Jul 28, 2026 383.25 398.00 382.21 393.10 390.86 3,414,442
Jul 27, 2026 378.55 382.28 374.39 376.26 374.11 2,903,315
Jul 24, 2026 372.73 379.41 372.16 376.04 373.89 2,493,927
Jul 23, 2026 359.98 371.84 359.21 371.50 369.38 2,931,905
Jul 22, 2026 369.23 371.00 364.86 366.05 363.96 1,548,450
Jul 21, 2026 365.08 368.91 362.14 366.24 364.15 2,881,907
Jul 20, 2026 367.95 370.29 363.65 364.17 362.09 1,922,161
Jul 17, 2026 373.97 378.54 361.72 366.29 364.20 2,861,314
Jul 16, 2026 358.25 372.14 357.74 371.58 369.46 2,355,743
Jul 15, 2026 354.66 359.90 353.95 358.32 356.28 1,837,923
Jul 14, 2026 358.18 358.86 354.71 355.25 353.22 1,862,958
Jul 13, 2026 363.04 363.29 355.73 360.45 358.39 2,064,665
Jul 10, 2026 363.08 364.89 361.14 363.39 361.32 1,632,715
Jul 9, 2026 367.82 368.75 361.03 363.62 361.55 1,728,241
Jul 8, 2026 366.19 371.42 363.00 367.99 365.89 1,758,925
Jul 7, 2026 374.28 375.25 366.36 368.10 366.00 1,983,666
Jul 6, 2026 371.70 373.98 359.47 366.44 364.35 2,838,007
Jul 2, 2026 364.74 375.15 363.39 374.15 372.02 2,487,837
Jul 1, 2026 362.63 364.00 357.89 361.33 359.27 2,244,791
Jun 30, 2026 362.15 362.78 356.87 362.12 360.06 2,246,908
Jun 29, 2026 361.95 363.11 358.46 360.55 358.49 2,461,887
Jun 26, 2026 354.69 362.27 354.16 358.33 356.29 3,610,561
Jun 25, 2026 350.06 359.10 350.06 352.82 350.81 2,341,847
Jun 24, 2026 348.00 354.42 346.00 351.43 349.43 2,391,890
Jun 23, 2026 348.31 349.40 345.49 347.01 345.03 2,304,951
Jun 22, 2026 337.65 345.11 337.60 344.72 342.75 2,520,964
Jun 18, 2026 344.38 345.00 334.05 337.60 335.68 8,151,089
Jun 17, 2026 347.08 349.40 338.90 341.66 339.71 3,470,311
Jun 16, 2026 352.00 353.66 345.87 347.84 345.86 3,516,790
Jun 15, 2026 355.50 358.30 349.56 350.53 348.53 4,371,390
Jun 12, 2026 357.39 358.17 351.96 355.20 353.17 2,730,230
Jun 11, 2026 342.91 358.46 341.45 354.06 352.04 4,727,125
Jun 10, 2026 346.86 348.59 337.49 337.73 335.80 3,000,395
Jun 9, 2026 348.24 349.64 342.62 344.56 342.60 3,388,246
Jun 8, 2026 349.34 352.17 344.24 345.73 343.76 2,488,219
Jun 5, 2026 348.76 356.50 347.66 349.58 347.59 3,451,237
Jun 4, 2026 345.87 349.18 342.25 345.60 343.63 2,907,078
Jun 3, 2026 327.98 338.70 325.98 338.22 336.29 2,289,315
Jun 2, 2026 326.17 329.46 322.30 328.26 326.39 1,558,780
Jun 1, 2026 333.38 333.83 326.35 329.13 327.25 2,120,812
May 29, 2026 336.22 337.51 333.06 336.79 334.87 2,954,439
May 28, 2026 336.44 337.95 334.15 336.48 334.56 2,159,406
May 27, 2026 339.52 341.39 335.99 336.06 334.14 1,929,982
May 26, 2026 340.56 342.49 335.20 335.94 334.02 1,860,952
May 22, 2026 340.26 343.80 338.40 339.30 337.37 1,567,235
May 21, 2026 330.00 337.63 329.09 337.42 335.50 2,001,113
May 20, 2026 330.75 333.53 326.80 331.57 329.68 4,074,397
May 19, 2026 323.25 332.34 320.96 330.75 328.86 3,040,404
May 18, 2026 325.55 325.77 321.21 324.39 322.54 2,030,276
May 15, 2026$2.52 dividend 336.23 336.23 325.16 326.31 324.45 3,447,804
May 14, 2026 336.26 337.94 333.47 336.23 331.75 2,041,584
May 13, 2026 332.32 338.00 330.06 336.45 331.97 2,183,792
May 12, 2026 331.95 338.49 329.80 336.29 331.81 3,119,091
May 11, 2026 332.99 334.19 327.62 329.59 325.20 1,918,848
May 8, 2026 329.48 332.33 328.00 331.70 327.28 2,443,294
May 7, 2026 330.39 331.28 327.22 329.09 324.70 3,296,982
May 6, 2026 329.13 332.98 329.05 331.11 326.70 2,874,747
May 5, 2026 321.91 329.66 320.52 329.59 325.20 3,321,411
May 4, 2026 326.03 326.79 321.92 323.85 319.54 3,481,360
May 1, 2026 332.52 337.00 324.63 329.82 325.43 3,821,061
Apr 30, 2026 340.75 349.54 340.05 346.25 341.64 3,592,568
Apr 29, 2026 335.01 339.12 333.55 338.02 333.52 2,516,505
Apr 28, 2026 344.50 346.02 337.82 339.57 335.05 2,376,361
Apr 27, 2026 342.35 348.04 339.98 340.18 335.65 2,653,848
Apr 24, 2026 346.00 347.66 342.52 344.55 339.96 2,201,408
Apr 23, 2026 345.51 350.69 345.50 348.62 343.98 2,033,441
Apr 22, 2026 344.09 347.68 342.97 345.92 341.31 2,136,485
Apr 21, 2026 350.23 350.23 340.06 344.86 340.26 2,066,855
Apr 20, 2026 354.25 356.90 350.02 350.16 345.50 2,107,613
Apr 17, 2026 351.89 356.69 349.42 355.30 350.57 3,686,080
Apr 16, 2026 346.63 351.25 346.60 349.39 344.74 1,981,741
Apr 15, 2026 351.70 352.60 344.21 348.22 343.58 2,140,010
Apr 14, 2026 346.18 351.72 345.41 350.95 346.27 2,106,765
Apr 13, 2026 352.09 352.62 345.49 349.82 345.16 2,547,886
Apr 10, 2026 357.46 357.46 349.75 351.02 346.34 2,258,054
Apr 9, 2026 347.46 359.44 346.42 355.60 350.86 2,940,906
Apr 8, 2026 345.61 351.33 342.35 349.81 345.15 2,666,481
Apr 7, 2026 340.99 341.87 335.06 340.00 335.47 3,162,242
Apr 6, 2026 345.45 348.17 340.64 342.57 338.01 2,144,062
Apr 2, 2026 352.72 354.16 345.87 347.94 343.30 1,604,273
Apr 1, 2026 354.90 357.00 351.66 353.28 348.57 2,726,787
Mar 31, 2026 350.73 355.49 347.11 351.85 347.16 3,747,125
Mar 30, 2026 351.83 351.83 348.13 349.00 344.35 2,590,304
Mar 27, 2026 355.66 355.66 347.80 348.77 344.12 2,274,881
Mar 26, 2026 350.33 354.81 348.51 353.16 348.45 2,044,901
Mar 25, 2026 350.76 358.00 350.76 353.93 349.21 1,831,992
Mar 24, 2026 346.56 352.58 345.80 348.43 343.79 2,337,061
Mar 23, 2026 351.80 353.42 348.61 349.77 345.11 2,368,845
Mar 20, 2026 348.01 351.25 344.95 347.80 343.17 9,169,034
Mar 19, 2026 353.30 356.32 347.85 349.92 345.26 2,168,750
Mar 18, 2026 359.82 360.69 350.81 351.48 346.80 2,895,425
Mar 17, 2026 368.24 368.78 359.80 361.13 356.32 2,334,329
Mar 16, 2026 369.38 370.89 364.72 366.25 361.37 2,099,105
Mar 13, 2026 370.68 372.98 365.93 366.21 361.33 1,500,319
Mar 12, 2026 373.51 375.00 367.76 367.79 362.89 1,990,663
Mar 11, 2026 375.05 380.14 373.00 377.64 372.61 2,300,019
Mar 10, 2026 376.17 379.26 372.74 375.43 370.43 2,284,548
Mar 9, 2026 368.27 378.81 366.53 376.97 371.95 2,720,112
Mar 6, 2026 364.20 369.76 361.70 369.53 364.61 2,443,031
Mar 5, 2026 375.18 377.09 361.39 367.60 362.70 2,870,269
Mar 4, 2026 380.00 380.09 370.82 379.27 374.22 2,028,437
Mar 3, 2026 377.97 381.74 372.71 377.00 371.98 2,710,556
Mar 2, 2026 388.00 391.29 381.89 385.70 380.56 2,838,162
Feb 27, 2026 379.29 390.14 378.75 388.16 382.99 3,441,042
Feb 26, 2026 385.14 385.14 374.25 379.33 374.28 2,589,643
Feb 25, 2026 381.50 387.49 380.54 384.33 379.21 2,459,756
Feb 24, 2026 380.02 383.20 378.82 382.87 377.77 2,454,816
Feb 23, 2026 375.26 381.78 374.74 379.42 374.37 2,951,656
Feb 20, 2026 372.01 377.00 371.39 374.75 369.76 2,911,727
Feb 19, 2026 377.91 379.93 374.13 375.50 370.50 2,427,130
Feb 18, 2026 373.50 380.58 370.44 379.73 374.67 2,731,996
Feb 17, 2026 370.88 374.77 369.00 373.36 368.39 2,255,695
Feb 13, 2026$2.52 dividend 362.65 370.42 361.71 369.19 364.27 2,414,170
Feb 12, 2026 366.66 370.88 365.06 366.20 358.87 2,374,457
Feb 11, 2026 365.14 368.51 361.00 366.58 359.24 2,826,184
Feb 10, 2026 377.04 377.36 363.65 364.65 357.35 3,526,589
Feb 9, 2026 380.70 384.62 372.34 375.82 368.30 2,844,017
Feb 6, 2026 369.99 385.12 368.90 384.32 376.63 3,840,306
Feb 5, 2026 365.73 374.90 365.00 367.80 360.44 4,007,341
Feb 4, 2026 352.03 368.75 342.38 366.20 358.87 5,899,557
Feb 3, 2026 341.24 349.50 338.59 338.59 331.81 4,039,974
Feb 2, 2026 339.47 345.98 339.41 344.68 337.78 1,899,871
Jan 30, 2026 340.81 345.50 338.07 341.88 335.04 2,522,788
Jan 29, 2026 341.66 347.27 338.75 342.94 336.08 3,153,100
Jan 28, 2026 349.00 351.95 340.00 342.22 335.37 2,347,790
Jan 27, 2026 348.57 353.25 346.93 351.32 344.29 3,269,988
Jan 26, 2026 344.70 350.43 343.62 349.69 342.69 3,116,275
Jan 23, 2026 346.18 349.23 341.81 344.75 337.85 2,024,980
Jan 22, 2026 344.14 349.98 342.14 347.07 340.12 3,025,150
Jan 21, 2026 329.95 343.98 329.31 343.60 336.72 4,148,714
Jan 20, 2026 325.58 331.34 321.71 331.00 324.38 2,947,821
Jan 16, 2026 328.70 333.03 326.90 330.41 323.80 4,033,805
Jan 15, 2026 328.97 332.50 325.19 330.03 323.43 2,592,019
Jan 14, 2026 324.09 329.20 323.55 328.97 322.39 1,897,473
Jan 13, 2026 327.42 327.75 319.79 324.30 317.81 2,382,206
Jan 12, 2026 328.47 328.47 322.74 325.54 319.02 2,460,632
Jan 9, 2026 328.81 332.07 323.89 326.10 319.57 2,118,681
Jan 8, 2026 337.76 341.46 328.21 330.11 323.50 2,799,481
Jan 7, 2026 332.10 343.05 332.10 341.64 334.80 3,599,398
Jan 6, 2026 319.49 330.94 318.83 330.17 323.56 2,722,530
Jan 5, 2026 324.92 326.52 318.21 320.72 314.30 2,268,871
Jan 2, 2026 328.77 329.19 325.01 327.64 321.08 1,539,731
Dec 31, 2025 328.69 329.50 327.06 327.31 320.76 1,417,378
Dec 30, 2025 328.65 329.77 325.83 328.69 322.11 1,256,185
Dec 29, 2025 332.46 333.50 329.47 329.63 323.03 2,181,413
Dec 26, 2025 333.65 333.98 330.85 332.93 326.27 792,583
Dec 24, 2025 330.72 334.38 330.72 333.96 327.28 833,663
Dec 23, 2025 328.09 333.67 328.07 331.49 324.86 1,552,919
Dec 22, 2025 327.01 331.88 326.08 331.39 324.76 2,400,422
Dec 19, 2025 325.56 331.50 324.73 327.38 320.83 13,465,864
Dec 18, 2025 326.27 328.24 321.91 324.42 317.93 2,669,255
Dec 17, 2025 327.51 330.04 325.43 326.01 319.49 2,517,497
Dec 16, 2025 324.82 327.34 323.02 326.74 320.20 2,642,465
Dec 15, 2025 321.21 325.76 319.06 325.31 318.80 4,049,462
Dec 12, 2025 317.30 319.46 315.19 317.74 311.38 2,247,321
Dec 11, 2025 317.89 320.19 312.38 317.38 311.03 2,455,125
Dec 10, 2025 316.25 317.47 313.00 315.38 309.07 3,071,492
Dec 9, 2025 321.81 323.00 313.18 313.85 307.57 2,925,118
Dec 8, 2025 329.09 329.67 320.17 321.23 314.80 3,510,785
Dec 5, 2025 340.36 340.88 328.63 329.89 323.29 2,897,992
Dec 4, 2025 344.23 346.33 338.94 340.16 333.35 3,695,846
Dec 3, 2025 340.54 346.38 338.85 345.42 338.51 2,839,394
Dec 2, 2025 338.86 342.50 336.33 338.36 331.59 2,446,819
Dec 1, 2025 343.07 343.98 336.25 337.49 330.74 2,384,122
Nov 28, 2025 344.00 345.66 342.26 345.46 338.55 1,268,802
Nov 26, 2025 341.52 345.03 340.00 344.57 337.67 2,333,053
Nov 25, 2025 335.41 341.73 335.41 341.11 334.28 2,868,739
Nov 24, 2025 335.84 338.66 331.70 334.30 327.61 3,551,616
Nov 21, 2025$2.38 dividend 334.87 342.84 334.74 337.54 330.79 4,128,726
Nov 20, 2025 344.52 345.09 335.00 336.07 327.04 3,184,112
Nov 19, 2025 343.47 345.29 340.02 342.40 333.20 2,129,822
Nov 18, 2025 343.73 345.49 339.30 343.99 334.75 2,966,636
Nov 17, 2025 337.64 344.06 336.82 341.71 332.53 2,996,550
Nov 14, 2025 336.74 339.80 330.35 336.74 327.69 3,310,332
Nov 13, 2025 337.90 345.84 335.12 336.00 326.97 3,413,466
Nov 12, 2025 338.64 342.40 335.81 336.28 327.24 2,941,162
Nov 11, 2025 323.42 338.55 323.42 338.45 329.36 3,136,543
Nov 10, 2025 320.60 326.18 319.54 323.66 314.96 2,518,593
Nov 7, 2025 316.08 321.42 314.00 320.20 311.60 2,665,384
Nov 6, 2025 319.10 321.31 312.52 315.59 307.11 3,330,531
Nov 5, 2025 303.12 322.98 302.13 319.86 311.26 5,486,162
Nov 4, 2025 298.71 299.06 294.48 296.70 288.73 3,412,532
Nov 3, 2025 298.43 301.00 292.12 296.30 288.34 2,753,331
Oct 31, 2025 288.46 298.88 288.00 298.43 290.41 2,687,516
Oct 30, 2025 290.58 294.56 289.00 292.00 284.15 2,058,158
Oct 29, 2025 291.76 294.81 289.44 291.77 283.93 2,824,472
Oct 28, 2025 288.93 292.63 288.26 292.09 284.24 2,217,623
Oct 27, 2025 291.21 292.00 288.26 291.16 283.33 1,794,617
Oct 24, 2025 292.89 293.94 290.66 291.76 283.92 1,376,330
Oct 23, 2025 296.01 296.46 291.91 292.89 285.02 1,496,922
Oct 22, 2025 301.29 302.81 295.60 295.98 288.03 1,698,899
Oct 21, 2025 302.60 303.85 298.03 301.14 293.05 1,533,558
Oct 20, 2025 299.48 303.66 297.75 303.33 295.18 1,613,514
Oct 17, 2025 295.24 299.37 293.14 298.81 290.78 1,959,530
Oct 16, 2025 298.07 302.26 294.44 295.81 287.86 1,715,049
Oct 15, 2025 292.81 298.21 292.43 297.32 289.33 2,502,083
Oct 14, 2025 291.75 296.87 290.97 293.85 285.95 1,975,949
Oct 13, 2025 291.75 296.13 289.44 292.40 284.55 1,838,558
Oct 10, 2025 296.16 297.09 289.58 290.13 282.33 2,660,454
Oct 9, 2025 294.13 296.63 293.70 295.43 287.49 1,369,162
Oct 8, 2025 295.79 297.62 292.29 294.62 286.70 2,940,781
Oct 7, 2025 293.27 295.85 290.21 295.54 287.60 1,504,255
Oct 6, 2025 297.62 297.62 293.03 294.12 286.22 1,957,330
Oct 3, 2025 297.72 301.54 295.63 297.89 289.88 2,518,707
Oct 2, 2025 298.31 300.50 295.46 297.40 289.41 2,123,343
Oct 1, 2025 284.45 301.66 283.00 298.50 290.48 4,835,353
Sep 30, 2025 274.14 284.81 274.02 282.20 274.62 3,508,730
Sep 29, 2025 273.10 274.52 270.67 273.97 266.61 1,769,344
Sep 26, 2025 274.34 275.50 269.77 272.98 265.64 1,812,192
Sep 25, 2025 279.00 281.05 270.64 271.18 263.89 2,802,669
Sep 24, 2025 285.47 286.70 278.00 279.22 271.72 2,374,569

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Amgen Inc Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at AMGN, per a recent SEC DEF 14A filing. We estimate that the median employee at AMGEN INC is paid $154,123.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation